ESC Premium Access

Stroke rate after twelve versus 30 month dual antiplatelet therapy in percutaneous coronary intervention patients using korean national health insurance service (nhis)

Congress Presentation

About the speaker

Miss Sayul Kang

Busan (Korea (Republic of))
0 follower

6 more presentations in this session

Temporal trends in the use of antiplatelet therapy in patients with acute coronary syndromes

Speaker: Doctor M. Esteve Pastor (Murcia, ES)

Thumbnail

The effect of CYP2C19 gene polymorphism on clinical outcomes in patients with CAD receiving antiplatelet therapy.

Speaker: Mr W. Liu (Beijing, CN)

Thumbnail

Efficacy and safety of perioperative aspirin therapy in non-cardiac surgery: a systematic review and comprehensive meta-analysis of randomized controlled trials

Speaker: Mr G. Wolff (Duesseldorf, DE)

Thumbnail

Antiplatelet therapy and adverse outcomes in high cardiovascular risk elderly patients: a sex and gender focused analysis from REPOSI study

Speaker: Doctor M. Proietti (Milan, IT)

Thumbnail

Anti-platelet effect of intravenous P2Y12 receptor inhibitor cangrelor is not influenced by reticulated platelets

Speaker: Doctor C. Stratz (Bad Krozingen, DE)

Thumbnail

Access the full session

Remaining in the spotlight: antiplatelet agents

Speakers: Miss S. Kang, Doctor M. Esteve Pastor, Mr W. Liu, Mr G. Wolff, Doctor M. Proietti...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk